XLIFE SCIENCES AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.8 EUR | -0.48% |
|
-7.52% | -3.69% |
| Apr. 23 | Xlife Sciences Posts Higher FY23 Profit; Revenue Falls | MT |
| Feb. 29 | Xlife Sciences AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Xlife Sciences AG
Price target over the last 5 years
History of analyst recommendation changes
255292.ZX7dbEfqe5MzhLP3qzwc-dceOzPQjp_pYxAiR3pfAcM.FiSJWQmbSKBKsofGwk5frZ1UU1iV-tiYBVtwEyMzRa82GpsIJLUKxUXe6g~5569506f6b67f3191281612a081759e2
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
35.3
CHF
Average target price
68
CHF
Spread / Average Target
+92.63%
High Price Target
68
CHF
Spread / Highest target
+92.63%
Low Price Target
68
CHF
Spread / Lowest Target
+92.63%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- XLS Stock
- XLS Stock
- Consensus Xlife Sciences AG
